INTRODUCTION
The spontaneously hypertensive rat (SHR) is a widely studied rodent model of human metabolic Syndrome X, in which hypertension is associated with dyslipidemia and with insulin resistance of glucose metabolism (1) . Two quantitative trait loci (QTLs) for defective insulin action in the SHR were identified on chromosomes 4 and 12. QTLs for defects in glucose and fatty acid metabolism and for hypertension map to the same locus on chromosome 4 (1). Microarray screening and congenic mapping identified CD36 on rat chromosome 4 as a defective SHR gene at the peak of linkage to these QTLs (2) . The SHR CD36 cDNA contains multiple sequence variants and the protein product is undetectable in SHR adipocyte plasma membrane (2) .
CD36 was identified on platelets (3) as a receptor for thrombospondin, collagen (4) and oxidized lipoproteins (5) . CD36 is also known as FAT for fatty acid translocase (6) since its function in long-chain FA transport was identified from its binding the reactive FA derivative sulfo-N-succinimidyl oleic acid (SSO), an irreversible inhibitor of FA uptake by rat adipocytes (7) .
Results of in vitro studies provided strong support for a role of CD36 in FA transport (8) . Recent work with CD36 null (9, 10) and transgenic (11) mice documented that CD36 facilitates a major fraction of FA uptake by heart, oxidative skeletal muscle and adipose tissues.
Based on the role of CD36 as a FA transporter, it was proposed that a primary genetic defect in the SHR is compromised tissue utilization of FA (2) , which would contribute to the CD36 null mouse. The CD36 null mouse, in contrast to the SHR is hypoglycemic (9) and hypoinsulinemic (Hajri, 2000, unpublished observations) while the mouse with CD36 overexpression exhibits the opposite changes (11). Also complicating the link between CD36 deficiency and the SHR phenotype are reports that some SHR lines, which apparently have normal CD36 levels, exhibit symptoms of insulin resistance (13, 15) . There is no information on whether SHR tissues have loss of CD36 function. The CD36 protein deficiency in SHR was based on reaction of adipose tissue membranes with a polyclonal antibody against rat CD36, which may have failed to recognize a mutated protein that is partially or completely functional. In addition, it is not known if CD36 has a dominant role in FA transport in rat tissues and if its loss would have similar consequences to those observed in the mouse.
We have compared uptake of FA and glucose by tissues of SHR, WKY and the congenic SHRchr4line (13) and tested whether diet supplementation with short-chain FA, which do not require CD36 for uptake, can improve the hyperinsulinemia and other abnormalities of the SHR.
Experimental Procedures:
Animals and diets-Breeding pairs for SHR (NCrlBR) and WKY (NCrlBR) controls were purchased from the Charles River Company. The congenic SHR line (SHR.BN-Il6/Npy) harboring a segment of chromosome 4 containing CD36 (referred to here as SHRchr4) was generated by
The basal diet used was the standard chow Purina diet (# 5001) rich in carbohydrate (50% of total weight) and containing a low proportion of fat (4.5 %) mostly as polyunsaturated fatty acids. The supplemented diet was prepared by adding 15g of short and medium chain triacylglycerols (Captex 300, Arbitec Co) to 100 g of basal diet followed by thorough mixed with a mechanical food blender. The composition of Captex 300 was 6% as caproic (C 6 ), 65.6% as caprylic (C 8 ) and 29.2 % as capric (C 10 ). The final diet contained 21% fat (38% of total energy) of which 79% was short and medium chain fatty triacylglycerols. Rats were started on the diet at one week after weaning.
Systolic arterial blood pressure was measured in awake rats by the indirect tail cuff method using a Physiograph (Narco Biosystem, Houston, TX) equipped with transducers and preamplifiers.
Analysis of plasma parameters--Rats were fasted overnight (16 hrs) and tail vein blood was collected into heparinized or EDTA (for FA determination) containing tubes. Plasma free fatty acids (FFA) were measured using the Wako kit (Wako Chemicals, Richmond, VA). Triglycerides, cholesterol and glucose were measured using enzymatic kits from Sigma Diagnostics (St Louis MO). Plasma insulin was tested using a radioimmunoassay kit for rat insulin from Linco Research Inc. (St. Louis, MO).
Oral glucose tolerance test (OGTT):
Rats, fasted overnight were given a 25% glucose solution (1.5g/kg) orally using an intubation needle. Blood was collected for glucose determination from the tail prior to and at 10, 20, 30, 45, 90 and 120 min after the load. Glucose was measured using a Precision Q.I.D. monitoring system. BMIPP Preparation--BMIPP was radioiodinated by the thallation-iodide exchange method and purified over a Sep-Pak RP-18 Light cartridge (Waters Corp.), as previously described (16 For westerns, adipose tissue was homogenized in 1 ml of ice-cold TES buffer (20 mM Tris, 1 mM EDTA, 250 mM sucrose). The homogenate was centrifuged (16,000 × g) to yield a pellet (P1), which was layered on 38% sucrose and centrifuged at 86,000 × g to pellet out mitochondria and nuclei (P2). The band at the interphase was harvested, diluted (1:7) in TES buffer, and centrifuged at 350,000 × g to yield a total microsomal pellet (P3). Samples from both P1 and P3 (20-50 µg of protein) were subjected to electrophoresis according to Laemmli (18) followed by transfer to a nylon-supported nitrocellulose membrane. Briefly, the membrane was incubated with anti-CD36
antibody (2 h, 1:1000 dilution), washed, then incubated (1 h, 1:10,000) with secondary antibody labeled with horseradish peroxidase. Detection of immune complex was according to the directions of the ECL kit (Amersham Pharmacia Biotech).
Preparation of adipocytes and cardiomyocytes-Adipocytes were isolated from the epididymal fat of male rats after tissue digestion with collagenase type I (1 mg/ml, Worthington Biochem).
Suspensions were kept at a lipocrit of 30% and assayed as described earlier (19) and in the legend of Figure 4 . Cardiomyocytes were isolated from perfused hearts as described by Luiken et al (20) . Suspensions were kept at about 25% cell density and were assayed within 2 hrs after isolation using the same assay conditions as for adipocytes.
RESULTS:
FA uptake is reduced in heart and adipose tissues of SHR-- defect in BMIPP uptake by oxidative skeletal muscle, heart and adipose tissue and the magnitude of the defect is similar when data from BMIPP are compared to those with the rapidly oxidized FA analog, IPPA, or with native palmitate (10).
The biodistribution data for BMIPP in SHR and WKY showed that of the several tissues examined, which included blood, liver, intestine, lung, hip muscle, heart and adipose tissue, impaired BMIPP uptake in SHR was observed only in heart (25%) and fat tissue (60%) (Fig. 1 ).
In CD36 null mice, tissues where FA uptake was deficient exhibited a defect in converting labeled diglycerides (DG) to triglycerides (TG) with a several fold increase in the ratio of DG to TG (10) . As shown in Fig. 2 , such a block in DG to TG conversion was also observed in SHR heart. Table 1 , which documents BMIPP lipid distribution for different tissues, shows that the defect in intracellular processing of BMIPP is observed in oxidative (diaphragm) but not in glycolytic (hip) muscles. It is also measured in the kidney and in adipose tissue but not in the liver. Another point documented by Table 1 is that the defect in intracellular incorporation of BMIPP is observed early during growth since the rats used in these experiments were aged 9-10 weeks, as opposed to 14-16 weeks in the experiment shown in Fig. 2 .
A significant finding in the oxidative tissues of the SHR is shown in Table 2 . Despite the defect in BMIPP uptake present in heart and diaphragm, there was a severalfold increase in accumulation of free BMIPP, a finding that was not observed in the CD36 null mouse.
The defective FA utilization present in some SHR tissues was paralleled by a compensatory increase in glucose uptake, as shown in Fig. 3 . A large increase in uptake of the glucose tracer 18 F-2-FDG was observed in heart and diaphragm. Smaller but still significant increases were measured in intercostal and hip muscles and in adipose tissue. These data are in line with our findings with the CD36 null mouse (Hajri et al., 2000, unpublished observations).
Since the ability to detect metabolic defects in the SHR may depend on the type of wild type strain used for comparison, we examined BMIPP and 2-FDG uptake in tissues from SHR and a congenic line (SHRchr4) that incorporates a piece of chromosome 4 containing wild type CD36. We also compared FA uptake by adipocytes isolated from the two lines. Panel A of Fig. 4 shows CD36 expression by adipose tissue from congenic SHRchr4, WKY and SHR using a We next tested whether the defect in FA uptake constitutes a primary cause of the hyperinsulinemia and insulin resistance observed in the SHR. We examined whether supplying SHR tissues with FA they can utilize would reverse the defects caused by lack of CD36. The saturable component of FA uptake, presumably facilitated by CD36, does not recognize shortchain FA (25). Also in line with this is the finding that pure CD36 does not bind short-chain FA.
SHR and WKY rats were started on the diet supplemented with short and medium-chain FA at about the 5 th week of age and maintained on it for a period of 3 months. As shown in Table   3 , there were no significant differences in body weights between WKY and SHR at the end of the 3-month diet treatment. However, a significant decrease in SHR heart weight and in the heart to body weight ratio was observed on the FA-supplemented diet. The effect was small and not significant in WKY. The decrease in heart weight occurred without a change in blood pressure, which remained significantly higher in the SHR and was largely unaffected by the diet. Table 4 shows that blood glucose levels were slightly increased by the FA-diet in both rat groups but were not significantly different between the groups on either diet. In contrast, insulin levels, which were about 2.4 times higher in SHR were normalized by the FA-supplemented diet while no effect was observed on blood insulin in the WKY. The FA-diet normalized the insulin/glucose ratio in SHR, which dropped from 1.4 to 0.4. Short-chain FA supplementation significantly decreased blood free FA and slightly increased blood TG in both groups.
To determine whether the lower insulin levels and insulin/glucose ratios in SHR fed the experimental diet reflected improved insulin responsiveness, glucose tolerance was examined in the two groups comparing basal and FA-supplemented diets (Fig. 5 ). SHR and WKY fed the FAdiet cleared glucose at similar rates, which mainly reflected a slower clearance in the WKY with little change in the SHR. The short-chain FA diet had a significant effect in sparing glucose utilization by SHR tissues. As shown in Fig. 6 , 18 F-2-FDG uptake by SHR hearts, which was greatly increased on the basal diet, was decreased to levels undistinguishable from those measured in WKY hearts.
DISCUSSION
The present study documents that the SHR exhibits loss of CD36 function in FA uptake in fat and oxidative muscle, tissues that normally express high CD36 levels (6). An associated defect in conversion of DG to TG is observed and may reflect an important role of CD36 in directing the FA to specific metabolic sites. Of note is the observation of a significant defect in BMIPP lipid incorporation in the kidney (Table 1) , which is a tissue with low CD36 levels, suggesting an important role of CD36 in the kidney cells where most TG accumulation occurs.
SHR tissues deficient in FA uptake exhibit a large increase in basal glucose uptake, which is eliminated by provision of short-chain FA that do not require CD36 for transport ( Fig. 6 and Table 4 ). The short-chain FA supplemented diet also eliminated the hyperinsulinemia of the SHR and lowered the fasting insulin/glucose ratio down to the level present in wild type mice. This indicates that short-chain FA may be beneficial when hyperinsulinemia and insulin resistance reflect defects in FA uptake. In line with this, a diet supplemented with short-(octanoic) and medium-chain FA decreased insulin levels and improved carbohydrate intolerance in a patient with lipodystrophy from lipoprotein lipase deficiency (26). In addition to the hyperinsulinemia, the FA-supplemented diet also alleviated SHR heart hypertrophy, which links the symptom to defective FA metabolism since it is reversed by provision of energy from FA oxidation (Table 3) .
In contrast to myocardial hypertrophy, hypertension was not improved indicating that it is independent of FA-generated energy. Although CD36 deficiency could be contributing to the hypertension, the link is complex and may reflect multiple influences as previously suggested (14) . It may be worth exploring whether short-chain FA supplementation may reverse some of the deleterious effects of CD36 deficiency in humans, which may include hypertrophic cardiomyopathy (27).
The magnitude of the myocardial FA defect is underestimated in the SHR by BMIPP as compared with the CD36 null mouse (25% in SHR versus about 60-80% in CD36 null mice (10)).
We believe this is most likely a result of rat versus mouse differences in cellular esterification of incoming FA, which is the process measured by BMIPP. TG levels are severalfold lower in the rat as compared to the mouse heart and they turnover less actively (28). As a result, FA incorporation into TG in the rat myocardium is affected much less than in the mouse by a drop in Presence of an additional defect in FA metabolism would be consistent with the report that the SHRSP line, which has CD36, exhibits insulin resistance (32) but it is not supported by direct data.
The free FA accumulation observed in SHR muscle is likely to play a role in the insulin resistance or hyperinsulinemia that are observed in this model (13) In summary, CD36 is important for FA uptake by adipose and muscle tissues of the rat and its deficiency in the SHR impairs FA oxidation to a larger extent than it impairs FA esterification. The disproportionate inhibition of FA oxidation coupled with the high rate of glucose utilization result in hyperinsulinemia and insulin resistance in the SHR and both abnormalities can be reversed by providing energy from FA oxidation. were detected using a polyclonal antibody against purified denatured rat adipose CD36.
Purified recombinant CD36 protein from a baculovirus expression system was used as a positive control on westerns. Data are typical of at least 3 experiments. Table 2 N=5 for the basal diet and 6 for the +FA diet.
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Heart W (g) 2.04+0.26 Values of the same row sharing the same superscript are significantly different with p<0.05 .
N=5 for the basal diet and 6 for the +FA diet.
Glucose (mg/dl) 63+2 
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